CN1111522A - Compound islets Langerhans regenerated capsule - Google Patents

Compound islets Langerhans regenerated capsule Download PDF

Info

Publication number
CN1111522A
CN1111522A CN 95101100 CN95101100A CN1111522A CN 1111522 A CN1111522 A CN 1111522A CN 95101100 CN95101100 CN 95101100 CN 95101100 A CN95101100 A CN 95101100A CN 1111522 A CN1111522 A CN 1111522A
Authority
CN
China
Prior art keywords
radix
rhizoma
regenerated
compound
capsule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 95101100
Other languages
Chinese (zh)
Inventor
李仲岭
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 95101100 priority Critical patent/CN1111522A/en
Publication of CN1111522A publication Critical patent/CN1111522A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention discloses a kind of capsule for reviving islets Langerhans and the preparation thereof. It is made from pure traditional Chinese medicinal ingredients. It features convenient for making, simple technology, through the clinical application, it not only has the obviously curative effect for diabetes but also has the outstanding result for diabetes mode I. There is no toxic side effect. The part of diabetic patients can be cured by this medicine.

Description

Compound islets Langerhans regenerated capsule
The present invention relates to a kind of compound islets Langerhans regenerated capsule for the treatment of type and preparation method thereof.
It is also many to suffer from the type person at present, their health mostly is under the internal and external factor influence, the islet cells that causes the pancreatic endocrine insulin, be seriously damaged, basically completely lost the function of normal excreting insulin, be a kind of extremely serious difficult pertinacious disease, particularly the life and health to youngsters and children is subjected to fatal threat.The unique better means of these type diabetes of treatment rely on insulin injection to earn a bare living exactly throughout one's life every day at present, and this results in hand cramps not only for patient and family members, and causes the lethal danger of hypoglycemic coma sometimes, finally can't solve root problem.
The objective of the invention is to avoid above-mentioned existing medicine weak point and for a kind of scientific formulation, simple for production, have no side effect, particularly type is had compound islets Langerhans regenerated capsule of outstanding curative effect and preparation method thereof.
Purpose of the present invention can realize by following measure: the present invention and preparation method thereof is by following component (by anharmonic ratio): Rhizoma Coptidis 2-10%, Radix Astragali 3-9%, Fructus Lycii 3-9%, Herba Patriniae 2-10%, Radix Salviae Miltiorrhizae 1-12%, Radix Angelicae Sinensis 1-10%, Radix Puerariae 3-10%, Radix Codonopsis 3-8%, Rhizoma Anemarrhenae 2-8%, Radix Scrophulariae 2-8%, Rhizoma Chuanxiong 1-9%, Radix Paeoniae Rubra 2-8%, Rhizoma Dioscoreae 1-9%, Rhizoma Polygonati 1-10%, Cortex Lycii 2-10%, Radix Rehmanniae 2-9%, Radix Rehmanniae Preparata 2-9%, Rhizoma Atractylodis 1-10%, Radix Ophiopogonis 2-9%, Poria 1-10%, Fructus Schisandrae Chinensis 1-5% etc. are formulated.
Optimum proportion of the present invention is (weight ratio): Rhizoma Coptidis 4-8%, Radix Astragali 4-8%, Fructus Lycii 4-8%, Herba Patriniae 4-8%, Radix Salviae Miltiorrhizae 4-8%, Radix Angelicae Sinensis 4-8%, Radix Puerariae 4-8%, Radix Codonopsis 3-7%, Rhizoma Anemarrhenae 3-7%, Radix Scrophulariae 3-7%, Rhizoma Chuanxiong 2-6%, Radix Paeoniae Rubra 2-6%, Rhizoma Dioscoreae 2-6%, Rhizoma Polygonati 2-6%, Cortex Lycii 2-6%, Radix Rehmanniae 2-6%, Radix Rehmanniae Preparata 2-6%, Rhizoma Atractylodis 2-6%, Radix Ophiopogonis 2-6%, Poria 2-6%, Fructus Schisandrae Chinensis 1-4%.
Preparation method of the present invention is: the component (weight ratio) of getting the Chinese medicine of respectively distinguishing the flavor of in the above-mentioned batching cleans up, put into 100 ℃ then and open the water that boils, sterilized 20-60% minute, pull each flavor Chinese medicine out oven dry again, be ground into smalls and mix homogeneously, promptly make medicine of the present invention in incapsulating.
To the above-mentioned best sterilization time of the Chinese medicine of respectively distinguishing the flavor of is 45 minutes.
The invention has the advantages that: production technology is simple, easy to make, has significant curative effect through clinical use treatment type, overcome the disadvantage of insulin injection, without any side effects again, the effect that can recover the normal excreting insulin of islet cells fully through taking for a long time is to reach the purpose of radical cure diabetes.
Further the present invention is illustrated with the following examples, but does not limit the present invention.
The embodiment I:
Get the percentage by weight of the Chinese medicine of respectively distinguishing the flavor of of the present invention, it is respectively: Rhizoma Coptidis 6%, the Radix Astragali 6%, Fructus Lycii 6%, Herba Patriniae 6%, Radix Salviae Miltiorrhizae 6%, Radix Angelicae Sinensis 6%, Radix Puerariae 6%, Radix Codonopsis 5%, the Rhizoma Anemarrhenae 5%, Radix Scrophulariae 5%, Rhizoma Chuanxiong 4%, Radix Paeoniae Rubra 4%, Rhizoma Dioscoreae 4%, Rhizoma Polygonati 4%, Cortex Lycii 4%, the Radix Rehmanniae 4%, Radix Rehmanniae Preparata 4%, Rhizoma Atractylodis 4%, Radix Ophiopogonis 4%, Poria 4%, Fructus Schisandrae Chinensis 3%, above-mentioned various Chinese medicines are cleaned up, put into 100 ℃ then and open the water that boils, sterilized 30 minutes, pull oven dry out, be ground into smalls, mix homogeneously is promptly made Chinese patent drug of the present invention in incapsulating.
Case 1: Zhu * *, the woman, 11 years old, the Zhengzhou Railway Administration families of workers and staff, suffered from type 3 years, every day, insulin injection was 3-4 time, per injection 24 μ, but blood glucose is still more than 11.2mm01/L, glucose in urine (++)-(++ ++) is through obeying compound islets Langerhans regenerated capsule of the present invention after two courses of treatment, stop the injection of insulin treatment fully, blood glucose maintains 4.5~6.0mm01/L always, glucose in urine (-) ketoboidies (-).
Embodiment 2:
Get the percentage by weight of the Chinese medicine of respectively distinguishing the flavor of of the present invention, be respectively: Rhizoma Coptidis 5%, the Radix Astragali 5%, Fructus Lycii 5%, Herba Patriniae 5%, Radix Salviae Miltiorrhizae 5%, Radix Angelicae Sinensis 5%, Radix Puerariae 5%, Radix Codonopsis 6%, the Rhizoma Anemarrhenae 6%, Radix Scrophulariae 6%, Rhizoma Chuanxiong 6%, Radix Paeoniae Rubra 6%, Rhizoma Dioscoreae 6%, Rhizoma Polygonati 6%, Cortex Lycii 3%, the Radix Rehmanniae 3%, Radix Rehmanniae Preparata 3%, Rhizoma Atractylodis 6%, Radix Ophiopogonis 3%, Poria 3%, Fructus Schisandrae Chinensis 2%, the above-mentioned Chinese medicine of respectively distinguishing the flavor of is cleaned up, put into 100 ℃ then and open the water that boils, sterilized 35 minutes, pull oven dry out, be ground into smalls, mix homogeneously is promptly made Chinese patent drug of the present invention in incapsulating.
Case 2: the merchant * *, the man, 15 years old, the Jiaozuo City people suffered from type insulin injection always over 3 years, each 16 μ, three times on the one, blood glucose is more than 15.6mm01/L, and glucose in urine (+++) is to (++ ++), and ketoacidosis once took place for several times in ketoboidies (+).Obey medicine of the present invention after four courses of treatment, stop insulinize, about blood glucose 5.2mm01/L, ketoacidosis did not take place in glucose in urine (-).
Example 3:
Get the Chinese medicine percentage by weight of respectively distinguishing the flavor of of the present invention, be respectively: Rhizoma Coptidis 4%, the Radix Astragali 4%, Fructus Lycii 4%, Herba Patriniae 4%, Radix Salviae Miltiorrhizae 4%, Radix Angelicae Sinensis 4%, Radix Puerariae 4%, Radix Codonopsis 4%, the Rhizoma Anemarrhenae 4%, Radix Scrophulariae 4%, Rhizoma Chuanxiong 3%, Radix Paeoniae Rubra 5%, Rhizoma Dioscoreae 5%, Rhizoma Polygonati 7%, Cortex Lycii 7%, the Radix Rehmanniae 6%, Radix Rehmanniae Preparata 6%, Rhizoma Atractylodis 5%, Radix Ophiopogonis 6%, Poria 6%, Fructus Schisandrae Chinensis 4%, the above-mentioned Chinese medicine of respectively distinguishing the flavor of is cleaned up, put into 100 ℃ then and open the water that boils, sterilized 40 minutes, pull oven dry out, be ground into smalls, mix homogeneously is promptly made Chinese patent drug of the present invention in incapsulating.
Case 3: horse * *, the woman, 62 years old, certain provincial hospital internal medicine was paid the chief physician, suffered from type 32 years, per injection insulin 28 μ, three times on the one, blood glucose is more than 7.3mm01/L, and glucose in urine (+) the hypoglycemia symptom occurred to (++ ++).After six courses of treatment, stop the injection of insulin treatment, and blood glucose maintains 4.1-6.0mm01/L through clothes medicine of the present invention, the hypoglycemia symptom did not take place in glucose in urine (-), ketoboidies (-).

Claims (4)

1, a kind of compound islets Langerhans regenerated capsule for the treatment of type, it is characterized in that: it is by following component (by weight): Rhizoma Coptidis 2-10%, Radix Astragali 3-9%, Fructus Lycii 3-9%, Herba Patriniae 2-10%, Radix Salviae Miltiorrhizae 1-12%, Radix Angelicae Sinensis 1-10%, Radix Puerariae 3-10%, Radix Codonopsis 3-8%, Rhizoma Anemarrhenae 2-8%, Radix Scrophulariae 2-8%, Rhizoma Chuanxiong 1-9%, Radix Paeoniae Rubra 2-8%, Rhizoma Dioscoreae 1-9%, Rhizoma Polygonati 1-10%, Cortex Lycii 2-10%, Radix Rehmanniae 2-9%, Radix Rehmanniae Preparata 2-9%, Rhizoma Atractylodis 1-10%, Radix Ophiopogonis, 2-9%, Poria 1-10%, Fructus Schisandrae Chinensis 1-5% etc. were formulated.
2, compound islets Langerhans regenerated capsule according to claim 1, it is characterized in that its optimum proportion (weight ratio) is: Rhizoma Coptidis 4-8%, Radix Astragali 4-8%, Fructus Lycii 4-8%, Herba Patriniae 4-8%, Radix Salviae Miltiorrhizae 4-8%, Radix Angelicae Sinensis 4-8%, Radix Puerariae 4-8%, Radix Codonopsis 3-7%, Rhizoma Anemarrhenae 3-7%, Radix Scrophulariae 3-7%, Rhizoma Chuanxiong 2-6%, Radix Paeoniae Rubra 2-6%, Rhizoma Dioscoreae 2-6%, Rhizoma Polygonati 2-6%, Cortex Lycii 2-6%, Radix Rehmanniae 2-6%, Radix Rehmanniae Preparata 2-6, Rhizoma Atractylodis 2-6%, Radix Ophiopogonis 2-6%, Poria 2-6%, Fructus Schisandrae Chinensis 1-4%.
3, a kind of preparation method for the treatment of the compound islets Langerhans regenerated capsule of type, it is characterized in that: with Rhizoma Coptidis, the Radix Astragali, Fructus Lycii, Herba Patriniae, Radix Salviae Miltiorrhizae, Radix Angelicae Sinensis, Radix Puerariae, Radix Codonopsis, the Rhizoma Anemarrhenae, Radix Scrophulariae, Rhizoma Chuanxiong, Radix Paeoniae Rubra, Rhizoma Dioscoreae, Rhizoma Polygonati, Cortex Lycii, the Radix Rehmanniae, Radix Rehmanniae Preparata, Rhizoma Atractylodis, Radix Ophiopogonis, Poria, Fructus Schisandrae Chinensis etc., getting the above-mentioned Chinese medicine component (weight ratio) of respectively distinguishing the flavor of cleans up, put into 100 ℃ then and open the water that boils, sterilized 20~60 minutes, pull each flavor Chinese medicine out oven dry again, be ground into smalls and mix homogeneously, promptly make medicine of the present invention in incapsulating.
4, the preparation method of compound islets Langerhans regenerated capsule according to claim 3 is characterized in that: the best sterilization time of each Chinese medicine of distinguishing the flavor of is 45 minutes.
CN 95101100 1995-01-10 1995-01-10 Compound islets Langerhans regenerated capsule Pending CN1111522A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 95101100 CN1111522A (en) 1995-01-10 1995-01-10 Compound islets Langerhans regenerated capsule

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 95101100 CN1111522A (en) 1995-01-10 1995-01-10 Compound islets Langerhans regenerated capsule

Publications (1)

Publication Number Publication Date
CN1111522A true CN1111522A (en) 1995-11-15

Family

ID=5073801

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 95101100 Pending CN1111522A (en) 1995-01-10 1995-01-10 Compound islets Langerhans regenerated capsule

Country Status (1)

Country Link
CN (1) CN1111522A (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1067260C (en) * 1997-05-08 2001-06-20 曾力群 Pure Chinese drug tangniaojing for curing diabetes
CN1071120C (en) * 1996-03-06 2001-09-19 宫君平 Shihua drink made from traditional Chinese medicine
CN1075735C (en) * 1999-09-07 2001-12-05 阎纯义 Compound diabetes-treating Chinese medicine preparation
CN100415270C (en) * 2000-10-20 2008-09-03 孙喆 Diabetes treating medicine
CN102614405A (en) * 2012-04-06 2012-08-01 刘英晓 Traditional Chinese medicine decoction for curing limb pain caused by diabetic neuropathy
CN103463407A (en) * 2013-03-24 2013-12-25 季成玉 Body regulating and blood sugar reducing capsule
CN103690768A (en) * 2013-11-18 2014-04-02 山西五台山沙棘制品有限公司 Creeping liriope-figwort-milkvetch root soft capsules and preparation method thereof
CN104352863A (en) * 2014-11-14 2015-02-18 刘玲 Medicine for treating insulin dependent diabetes mellitus as well as preparation method thereof
CN104689006A (en) * 2015-02-16 2015-06-10 广西世彪药业有限公司 Medicine for treating diabetes and preparation method of medicine
CN109157615A (en) * 2018-08-13 2019-01-08 李阳 It is a kind of to treat diabetes Chinese prescription

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1071120C (en) * 1996-03-06 2001-09-19 宫君平 Shihua drink made from traditional Chinese medicine
CN1067260C (en) * 1997-05-08 2001-06-20 曾力群 Pure Chinese drug tangniaojing for curing diabetes
CN1075735C (en) * 1999-09-07 2001-12-05 阎纯义 Compound diabetes-treating Chinese medicine preparation
CN100415270C (en) * 2000-10-20 2008-09-03 孙喆 Diabetes treating medicine
CN102614405B (en) * 2012-04-06 2015-03-11 刘英晓 Traditional Chinese medicine decoction for curing limb pain caused by diabetic neuropathy
CN102614405A (en) * 2012-04-06 2012-08-01 刘英晓 Traditional Chinese medicine decoction for curing limb pain caused by diabetic neuropathy
CN103463407A (en) * 2013-03-24 2013-12-25 季成玉 Body regulating and blood sugar reducing capsule
CN103463407B (en) * 2013-03-24 2016-06-08 季成玉 Reason machine Jiangtang capsule
CN103690768A (en) * 2013-11-18 2014-04-02 山西五台山沙棘制品有限公司 Creeping liriope-figwort-milkvetch root soft capsules and preparation method thereof
CN103690768B (en) * 2013-11-18 2016-05-11 山西五台山沙棘制品有限公司 Join stilbene soft capsule and preparation method thereof the tuber of dwarf lilyturf
CN104352863A (en) * 2014-11-14 2015-02-18 刘玲 Medicine for treating insulin dependent diabetes mellitus as well as preparation method thereof
CN104689006A (en) * 2015-02-16 2015-06-10 广西世彪药业有限公司 Medicine for treating diabetes and preparation method of medicine
CN109157615A (en) * 2018-08-13 2019-01-08 李阳 It is a kind of to treat diabetes Chinese prescription

Similar Documents

Publication Publication Date Title
US5908628A (en) Compositions with analgesic, antipyretic and antiinflammatory properties
CN101708302B (en) Chinese medicinal preparation for treating diabetes and preparation method thereof
CN100408064C (en) Prepn process of medicine for treating icteric diseases and oral liquid containing the medicine
CN1305844A (en) Medicine for treating congestive heart failure
CN100339120C (en) External applied medicine for treating prickly heat
CN1111522A (en) Compound islets Langerhans regenerated capsule
CN100522226C (en) Composition of Chinese traditional medicine for treating coronary heart disease
CN1329067C (en) Traditional Chinese medicine prepn. for treating diabetes
CN104225472B (en) A kind of Chinese medicine preparation and preparation method and purposes for treating Oral mucosal lesion
CN1054748C (en) Medicine for acne
CN1077896A (en) Medicine for psoriasis and manufacture method
CN1060368C (en) Traditional Chinese medicine Jinjiangkebao for treating cough
CN1127344C (en) Oral pill for curing diabetes and its complication
CN102652821B (en) Traditional Chinese medicine extract for treating yin deficiency and fire hyperactivity type phthisis and preparation method of traditional Chinese medicine extract
CN1063066C (en) Chinese medicine for treatment of gout
CN1241634C (en) Medicine for treating diabetes
CN1087821A (en) A kind of medicament and preparation method of removing acne
CN1117575C (en) Drug-dropping Chinese patent medicine for improving immunity of human body itself
CN108704064A (en) A kind of Chinese medicine composition and preparation method for treating AIDS
CN1100319A (en) Pancreatic islet recovering capsule and its preparing method
CN1259363A (en) Complex prescription capsule for strengthening yang and tonifying kidney and prepn. method thereof
CN1164283C (en) Pulmonotis treating Chinese medicine powder
CN1294934C (en) Prepared Chinese medicine for treating dribble urination caused by accumlated damp-heat and urination distrubance disease with dripping wet and unsmooth
CN1232673A (en) Chinese herbal decoction as oral liquid and its preparation and application
CN1306830A (en) Medicine for treating type II diabetes

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C01 Deemed withdrawal of patent application (patent law 1993)
WD01 Invention patent application deemed withdrawn after publication